We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Bio Ascend. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this live activity for a maximum of 9 AMA PRA Category 1 CreditsTM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As a jointly accredited provided, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing and commercial bias. All faculty, planners, and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, and re-selling, or financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
The activity may include presentation in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC or Bio Ascend.
The accredited provided has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of the content prior to assuming their roles:
Latifat Akintade, MD
No financial relationships to disclose
Julie Brahmer, MD, MS
Consultant: Amgen, AstraZeneca, GSK, RAPT Therapeutics, Sanofi Aventis
Pelin Cinar, MD, MS
Employer: Gilead Sciences
Nazli Dizman, MD
Stock/Ownership (Significant other): Medline Global Inc.
Consultant: Eisai
Jacqueline Gaddy, MD, MSc, MSCR
No financial relationships to disclose
Joanna Ghayad, PharmD, ACC
Employee: Bristol Myers Squibb
Jennifer Grandis, MD
No financial relationships to disclose
Carmen Guerra, MD, MSCE
Member, Advisory Board: Guardant Health, Natera, Roche
Grant (Institution): Genentech
Jenna Hatcher, RN, PhD
No financial relationships to disclose
Leora Horn, MD, MSc, MHPE, FRCPC
Employee: AstraZeneca
Dame Idossa, MD
Travel: Optum Health, Bio Ascend
Consulting: Trial Library
Shivani Kapur, MD
No financial relationships to disclose
Catherine Lai, MD
Advisor: Daiichi Sankyo, Novartis, Pfizer, Taiho Oncology
Consultant/Ad Board: AbbVie, Astellas, BMS, Rigel
Ad Board: Arcellx, Servier, Syndax
Honoraria: Bio Ascend
Consultant: Genentech, Jazz Pharma, PDS Biotechnology
Deepu Madduri, MD
Employee: Johnson & Johnson
Reshma Mahtani, MD
Consultant: Agendia, Daiichi Sankyo, Eisai, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma Biotechnology, Sanofi, Stemline, Sermonix Pharmaceuticals
Ariela Marshall, MD
No financial relationships to disclose
Rana McKay, MD
Consultant: Ambrx, Arcus, AstraZeneca, Aveo, Bayer, Blue Earth Diagnostics, Bristol-Myers Squibb, Calithera, Caris, Daiichi Sankyo, Dendreon, Exelixis, Johnson & Johnson, Lilly, Merck, Myovant, Neomorph, Novartis, Pfizer, Sanofi, SeaGen, Sorrento Therapeutics, Telix, Tempus
Neha Mehta-Shah, MD
Advisory Board/Consultant: Acrotech Biopharma, AstraZeneca, C4 Therapeutics, Genentech/Roche, Johnson & Johnson/Janssen, Ono Pharmaceuticals, Pfizer, Secura Bio/Red Nucleus, Verastem
Grant/Institutional Research Funding: AstraZeneca, Bristol Myers Squibb, C4 Therapeutics, Celgene, Corvus Pharmaceuticals, Daiichi Sankyo, Dizal Pharmaceuticals, Genentech/Roche, Innate Pharmaceuticals, MorphoSys, Seagen
Christiana Mo, MD
No financial relationships to disclose
Amanda Nizam, MD
Consulting or advisory role: AVEO Oncology*, Astellas Pharma, Seagen, Pfizer, EMD
Serono/Merck KGaA, Formedics (formerly Mashup Media), IDEOlogy Health*, Medscape
Honoraria: Cleveland Clinic*, Aptitude Health*, Targeted Oncology*, IntegrityCE*, MECC
Global Meetings, ASCO, Doximity*, Flatiron Health, SignifyMD
Bladder Cancer Section Editor: GU Oncology Now
Travel and accommodation expenses: ASCO, MECC Global Meetings, Formedics (formerly Mashup Media)
*Financial relationship ended
Coral Olazagasti, MD
Ad Board: BMS, Pfizer
Consultant: Lung Cancer Today
Sapna Patel, MD
No financial relationships to disclose
Shruti Patel, MD
No financial relationships to disclose
Elizabeth Plimack, MD
Scientific Advisory: AbbVie, AstraZeneca, BMS Eisai, EMD Serono, Flatiron, Astellas, Merck, Pfizer, SeaGen, Signatera, Synthekine, Aura Biosciences, Adaptimmune, 23andMe, Daiichi Sankyo
Gladys Rodriguez, MD
Stock ownership: Abbott Pharmaceuticals, Merck Pharmaceuticals, Novodisk
Lynn Schuchter, MD
No financial relationships to disclose
Lacey Scott Williams, MD
Consultant: Aptitude Health
Rachna Shroff, MD, MS, FASCO
Advisory Board: AstraZeneca, Boehringer Ingelheim Pharmaceuticals., Clovis, Genentech, Natera, Incyte, Merck, QED Therapeutics, Server, Zymeworks Biopharm., Astellas, Duo
Research Funding: IMV Inc., LOXO, Merck, Novocure, NUCANA, Bristol-Myers Squib, Pieris, QED Therapeutics, Seagen, Taiho, Bayer
Consulting: SYROS, Hookipa Pharma, AbbVie, Ability, Elevar Therapeutics
Surbhi Singhal, MD
Consultant: BMS, Caris Life Sciences, Oncohost
Eleonora Teplinsky, MD
Medical Advisory Board: Sermo
Consultant: AbbVie, AstraZeneca, Daiichi Sankyo, Immunogen, Novartis, Pfizer
Mazie Tsang, MD, MAS, MS
Advisory Board: AstraZeneca, Novartis, TerSera
Stock Ownership: Poseida Therapeutics
Research, Consultancy (to institution): ONO PHARMA, Eli Lilly, Genentech
Chaitra Ujjani, MD
Consultant: AbbVie, ADC Therapeutics, Alara, AstraZeneca, BeiGene, Genmab
Research: AbbVie, AstraZeneca, Lilly Pharmacyclics
Katherine Van Loon, MD, MPH
No financial relationships to disclose
Ana Velazquez Manana, MD
Consultant: AstraZeneca, BMS, Janssen, Merus, Regeneron
We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.